Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Mehta Vimal exercised options for 219 Bioxcel Therapeutics, Inc. shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Mehta Vimal (Director, CEO and President) exercised options for 219 Bioxcel Therapeutics, Inc. shares, leaving 69,817 shares. Filed Jun 17, 2026 (Form 4).
- Options exercised
- 219 shares
- Holding after
- 69,817 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 219 | 69,817 | Direct |
Source
Related
- Bioxcel Therapeutics, Inc.
- Mehta Vimal
- Bioxcel Therapeutics, Inc. shareholders
- Form 4 · Mehta Vimal · May 22, 2026
- Form 4 · Mehta Vimal · May 7, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · Rodriguez Javier · Jun 17, 2026
- Form 4 · Steinhart Richard I · Jun 17, 2026
- Form 4 · Yocca Frank · Jun 17, 2026
- Form 4 · Yocca Frank · May 22, 2026